학술논문
Burden of thyroid cancer in North Africa and Middle East 1990–2019
Document Type
article
Author
Seyed Aria Nejadghaderi; Sahar Saeedi Moghaddam; Sina Azadnajafabad; Negar Rezaei; Nazila Rezaei; Seyed Mohammad Tavangar; Hamidreza Jamshidi; Ali H. Mokdad; Mohsen Naghavi; Farshad Farzadfar; Bagher Larijani; GBD 2019 NAME Thyroid Cancer Collaborators; Mohsen Abbasi-Kangevari; Zeinab Abbasi-Kangevari; Sina Abdollahzade; Eman Abu-Gharbieh; Sima Afrashteh; Muhammad Sohail Afzal; Sajjad Ahmad; Ali Ahmadi; Sepideh Ahmadi; Haroon Ahmed; Luai A Ahmed; Hanadi Al Hamad; Fadwa Alhalaiqa Naji Alhalaiqa; Saba Alvand; Fazel Isapanah Amlashi; Ali Arash Anoushirvani; Jalal Arabloo; Seyyed Shamsadin Athari; Mohammadreza Azangou-Khyavy; Amirhossein Azari Jafari; Ali Bijani; Iman El Sayed; Iffat Elbarazi; Muhammed Elhadi; Pawan Sirwan Faris; Abbas Farmany; Ali Fatehizadeh; Azin Ghamari; Seyyed-Hadi Ghamari; Ahmad Ghashghaee; Pouya Goleij; Mohamad Golitaleb; Arvin Haj-Mirzaian; Rabih Halwani; Samer Hamidi; Soheil Hassanipour; Mowafa Househ; Tahereh Javaheri; Rovshan Khalilov; Ejaz Ahmad Khan; Javad Khanali; Maryam Khayamzadeh; Ali-Asghar Kolahi; Hamid Reza Koohestani; Somayeh Livani; Mohammad-Reza Malekpour; Ahmad Azam Malik; Entezar Mehrabi Nasab; Seyyedmohammadsadeq Mirmoeeni; Yousef Mohammad; Esmaeil Mohammadi; Abdollah Mohammadian-Hafshejani; Sara Momtazmanesh; Paula Moraga; Zuhair S Natto; Maryam Noori; Ali Nowroozi; Fatemeh Pashazadeh Kan; Zahra Zahid Piracha; Sima Rafiei; Kiana Ramezanzadeh; Mahsa Rashidi; Mohammad-Mahdi Rashidi; Reza Rawassizadeh; Nima Rezaei; Sahba Rezazadeh-Khadem; Basema Saddik; Umar Saeed; Amirhossein Sahebkar; Abdallah M Samy; Muhammad Arif Nadeem Saqib; Brijesh Sathian; Saeed Shahabi; Sarvenaz Shahin; Elaheh Shaker; Javad Sharifi-Rad; Parnian Shobeiri; Yasaman TaheriAbkenar; Iman M Talaat; Irfan Ullah; Rohollah Valizadeh; Bay Vo; Deniz Yuce; Iman Zare; Ali H Mokdad
Source
Frontiers in Oncology, Vol 12 (2022)
Subject
Language
English
ISSN
2234-943X
Abstract
BackgroundThyroid cancer is the leading cause of mortality and morbidity among cancers of the endocrine system. We aimed to describe the trends of thyroid cancer burden in North Africa and Middle East for 1990–2019.MethodsData on burden of thyroid cancer in North Africa and Middle East from 1990 to 2019 were obtained from the Global Burden of Disease (GBD) Study 2019. Decomposition analysis was used to estimate the effects of population growth, aging, and change in incident numbers on overall change of thyroid cancer incidence. Also, we used the comparative risk assessment framework of GBD to determine the burden of thyroid cancer attributable to a high body mass index (BMI).ResultsIn 2019, the age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) of thyroid cancer were 3.5 (2.9–4) and 0.5 (0.5–0.7) per 100,000, respectively. The highest age-standardized incidence, deaths, and disability-adjusted life year (DALY) rate were in Lebanon, Afghanistan, and United Arab Emirates, respectively. The ASIR of thyroid cancer in region was about 2.5 times higher among women, which had a positive association with increasing age. In 2019, the age-standardized deaths attributable to a high BMI was 16.7% of all deaths due to thyroid cancer. In 1990–2019, the overall change in thyroid cancer incident cases was a 396% increase which was mostly driven by the increase in disease-specific incidence rate (256.8%).ConclusionsWomen, the elderly above about 60 years old, and countries with a higher sociodemographic index showed higher incidence rates of thyroid cancer. Regarding our findings, it is recommended to establish preventive plans by modification in life style like weight reduction programs.